Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements

JACC Basic Transl Sci. 2019 Dec 11;5(1):15-31. doi: 10.1016/j.jacbts.2019.09.008. eCollection 2020 Jan.

Abstract

This study showed that bone marrow mononuclear cell pre-seeding had detrimental effects on functionality and in situ remodeling of bioresorbable bisurea-modified polycarbonate (PC-BU)-based tissue-engineered heart valves (TEHVs) used as transcatheter pulmonary valve replacement in sheep. We also showed heterogeneous valve and leaflet remodeling, which affects PC-BU TEHV safety, challenging their potential for clinical translation. We suggest that bone marrow mononuclear cell pre-seeding should not be used in combination with PC-BU TEHVs. A better understanding of cell-scaffold interaction and in situ remodeling processes is needed to improve transcatheter valve design and polymer absorption rates for a safe and clinically relevant translation of this approach.

Keywords: B-GLAP, bone gamma-carboxyglutamate; BMMNC, bone marrow mononuclear cells; BVG, bioresorbable vascular graft; CXCL12, stromal cell-derived factor-1α (SDF1α); ECM, extracellular matrix; IL, interleukin; MCP, monocyte chemoattractant protein; MMP, matrix metalloproteinase; PC-BU, polycarbonate bisurea; SMA, smooth muscle actin; TEE, transesophageal echocardiography; TEHV, tissue-engineered heart valve; TGF, transforming growth factor; TVR, transcatheter valve replacement; cardiovascular regenerative medicine; endogenous tissue regeneration; in situ tissue engineering; supramolecular polymer; tissue-engineered heart valve.